Bio-Path Holdings Appoints Paul Aubert to its Board of Directors
Feb 05, 2018 13:01 pm UTC| Business
HOUSTON, Feb. 05, 2018 -- Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid...
David Taing, MD, DC, CAQSM is Elected to the American Health Council’s Board of Physicians
Feb 05, 2018 13:01 pm UTC| Business
NEW YORK, Feb. 05, 2018 -- The American Health Council has elected David Taing, MD, DC, CAQSM, to its Board of Physicians. He is currently a Hospital-Employed Physician and Medical Director of two skilled nursing...
New Native Food Sovereignty Report and Videos Highlight Exemplary Work at the Grassroots Level
Feb 05, 2018 13:01 pm UTC| Business
Longmont, Colorado, Feb. 05, 2018 -- First Nations Development Institute (First Nations) has just published a new report on Native food sovereignty assessment efforts, as well as four new videos dealing with food...
Bel Will Report Fourth Quarter and Full Year 2017 Results on February 22, 2018
Feb 05, 2018 13:01 pm UTC| Business
JERSEY CITY, N.J., Feb. 05, 2018 -- Bel Fuse Inc. (“Bel,” or, “the Company”) (NASDAQ:BELFA) (NASDAQ:BELFB), a leading supplier of products that power, protect and connect electronic circuits, today announced that the...
Summer Infant to Hold Conference Call for Fourth Quarter 2017 Financial Results on February 21, 2018
Feb 05, 2018 13:00 pm UTC| Business
WOONSOCKET, R.I., Feb. 05, 2018 -- Summer Infant, Inc. ("Summer Infant" or the "Company") (NASDAQ:SUMR), a global leader in premium juvenile products, today announced that it will host a conference call to discuss...
Feb 05, 2018 13:00 pm UTC| Business
SAN JOSE, Calif., Feb. 05, 2018 -- Today, Cisco released the seventh annual Cisco® Global Cloud Index (2016-2021). The updated report focuses on data center virtualization and cloud computing, which have become...
Feb 05, 2018 13:00 pm UTC| Business
ROCKVILLE, Md., Feb. 05, 2018 -- Rexahn Pharmaceuticals, Inc. (NYSE American:RNN), a clinical stage biopharmaceutical company developing next generation therapeutics for the treatment of cancer, announced today that it...